Product Information

CAPTOPRIL 12.5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.2295 per EA under NDC 60687030421. Its NADAC has been published 276 times since May 12, 2021.

FDA first approved this application on Feb 13, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Captopril market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CAPTOPRIL 12.5 MG TABLET

Captopril
$0.2295per EA
Low Outlier

Strength

12.5 mg/1

NDC

60687030421

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CAPTOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA074505

FDA Approved

2/13/1996

TE Code

AB

On Market Since

12/12/2017

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for CAPTOPRIL 12.5 MG TABLET has been published 276 times since May 12, 2021, and over the history we have for it it has declined 62.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2295 per EA
All-time high$0.6898 (Apr 10, 2024)
All-time low$0.1816 (Mar 19, 2025)
52-week high$0.4059
52-week low$0.2295
Median price$0.4160
Average price$0.4112
Largest weekly change+125.8% (Aug 17, 2022)
Weeks tracked276
Tracking sinceMay 12, 2021

Price History

1W

-9.3%

1M

-9.3%

3M

-17.0%

6M

-31.0%

1Y

-20.4%

3Y

-53.0%

5Y

-45.2%

All

-62.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CAPTOPRIL 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 12.5 MG TABLET, manufactured by American Health Packaging, is $0.2295 per EA (NDC 60687030421), effective Aug 19, 2026.

How has the price of CAPTOPRIL 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPTOPRIL 12.5 MG TABLET has declined 62.9%. It has been tracked across 276 weekly CMS publications since May 12, 2021.

What are the highest and lowest recorded NADAC prices for CAPTOPRIL 12.5 MG TABLET?

Since May 12, 2021, the NADAC for CAPTOPRIL 12.5 MG TABLET has ranged from a low of $0.1816 (Mar 19, 2025) to a high of $0.6898 (Apr 10, 2024), with a median of $0.4160 per EA.

Are there cheaper alternatives to CAPTOPRIL 12.5 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPTOPRIL 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CAPTOPRIL 12.5 MG TABLET?

CAPTOPRIL 12.5 MG TABLET (NDC 60687030421) is labeled by American Health Packaging, and CMS classifies it as a generic product.